Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1143.96	14.12	-1.14
Graham Fair Price	-62.78	25.20	67.70
PEG	6188.70	-0.10	< 0.005
Price/Book	-16.74	1.97	2.37
Price/Cash Flow	-68.63	15.21	-48.51
Prices/Earnings	547.36	11.30	-1.74
Price/Sales	56.55	1.16	0.74
Price/FCF	-68.63	15.21	-48.51
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	625.60	0.09	0.01
Operating Margin	-91.41	0.05	-0.62
ROA	-82.52	< 0.005	-0.05
ROE	-0.34	0.04	-87.14
ROIC	-1.80	0.05	-97.25
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.13	0.41	-67.64
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-323.92	1.05	-99.68
EPS QOQ	-11.01	1.13	-89.71
FCF QOQ	-1.20	3.76	212.22
Revenue QOQ	0.56	-0.45	-20.17
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	8.64	12.13	40.43
Days Sales Outstanding (DSO)	61.85	102.94	66.42
Inventory Turnover	10.42	7.42	-28.79
Debt/Capitalization	0.15	0.16	7.71
Quick Ratio	1.22	1.27	4.09
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	24.51	25.44	3.79
Cash	10.33	22.57	118.41
Capex	0.42	0.19	-54.91
Free Cash Flow	-1.20	3.29	175.50
Revenue	78.22	43.17	-44.80
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.34	1.36	1.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.13	-4.70	3635.49
Naive Interpretation	Member

06 - Financial Health · Weak

Rating